Characterization of the Pharmacokinetics of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 in Human Whole Blood After Alcohol Consumption in a Clinical Laboratory Study

Alcoholism: Clinical and Experimental Research

Volumn 40, Issue 6, 2016, Pages 1228-1234

  Javors, Martin A ^a   Hill Kapturczak, Nathalie ^a   Roache, John D ^a   Karns Wright, Tara E ^a   Dougherty, Donald M ^a  

^a University of Texas Health Science Center   (United States)

Author keywords

Blood; Ethanol; HPLC MS MS; Pharmacokinetics; Phosphatidylethanol

Indexed keywords

ALCOHOL DERIVATIVE; PHOSPHATIDYLETHANOL; UNCLASSIFIED DRUG; ALCOHOL; BIOLOGICAL MARKER; GLYCEROPHOSPHOLIPID;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; FEMALE; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIMIT OF DETECTION; MALE; PRIORITY JOURNAL; SELF REPORT; SYNTHESIS; TANDEM MASS SPECTROMETRY; BLOOD; BREATH ANALYSIS; DOSE RESPONSE; DRINKING BEHAVIOR; MIDDLE AGED; YOUNG ADULT;

ADULT; ALCOHOL DRINKING; BIOMARKERS; BREATH TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; GLYCEROPHOSPHOLIPIDS; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84964614539     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.13062     Document Type: Article

References (29)

1. Alling C, Gustavsson L, Mansson JE, Benthin G, Anggard E (1984) Phosphatidylethanol formation in rat organs after ethanol treatment. Biochim Biophys Acta 793:119-122.
2. Aradottir S, Asanovska G, Gjerss S, Hansson P, Alling C (2006) Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. Alcohol Alcohol 41:431-437.
3. Dougherty DM, Hill-Kapturczak N, Liang Y, Karns TE, Lake SL, Cates SE, Roache JD (2015a) The potential clinical utility of transdermal alcohol monitoring data to estimate the number of alcoholic drinks consumed. Addict Disord Their Treat 14:124-130.
4. Dougherty DM, Karns TE, Mullen J, Liang Y, Lake SL, Roache JD, Hill-Kapturczak N (2015b) Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking. Drug Alcohol Depend 148:77-84.
5. First MB, Spitzer RL, Gibbon M, Williams JBW (2001) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). Biometrics Research, New York State Psychiatric Institute, New York.
6. Gnann H, Engelmann C, Skopp G, Winkler M, Auwarter V, Dresen S, Ferreiros N, Wurst FM, Weinmann W (2010) Identification of 48 homologues of phosphatidylethanol in blood by LC-ESI-MS/MS. Anal Bioanal Chem 396:2415-2423.
7. Gnann H, Thierauf A, Hagenbuch F, Rohr B, Weinmann W (2014) Time dependence of elimination of different PEth homologues in alcoholics in comparison with social drinkers. Alcohol Clin Exp Res 38:322-326.
8. Gnann H, Weinmann W, Thierauf A (2012) Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5 days. Alcohol Clin Exp Res 36:1507-1511.
9. Gustavsson L, Alling C (1987) Formation of phosphatidylethanol in rat brain by phospholipase D. Biochem Biophys Res Commun 142:958-963.
10. Hahn JA, Bwana MB, Javors MA, Martin JN, Emenyonu NI, Bangsberg DR (2010) Biomarker testing to estimate under-reported heavy alcohol consumption by persons with HIV initiating ART in Uganda. AIDS Behav 14:1265-1268.
11. Hahn JA, Dobkin LM, Mayanja B, Emenyonu NI, Kigozi IM, Shiboski S, Bangsberg DR, Gnann H, Weinmann W, Wurst FM (2012) Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa. Alcohol Clin Exp Res 36:854-862.
12. Hansson P, Caron M, Johnson G, Gustavsson L, Alling C (1997) Blood phosphatidylethanol as a marker of alcohol abuse: levels in alcoholic males during withdrawal. Alcohol Clin Exp Res 21:108-110.
13. Helander A, Peter O, Zheng Y (2012) Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting. Alcohol Alcohol 47:552-557.
14. Helander A, Zheng Y (2009) Molecular species of the alcohol biomarker phosphatidylethanol in human blood measured by LC-MS. Clin Chem 55:1395-1405.
15. Kip MJ, Spies CD, Neumann T, Nachbar Y, Alling C, Aradottir S, Weinmann W, Wurst FM (2008) The usefulness of direct ethanol metabolites in assessing alcohol intake in nonintoxicated male patients in an emergency room setting. Alcohol Clin Exp Res 32:1284-1291.
16. Kobayashi M, Kanfer JN (1987) Phosphatidylethanol formation via transphosphatidylation by rat brain synaptosomal phospholipase D. J Neurochem 48:1597-1603.
17. Maenhout TM, De Buyzere ML, Delanghe JR (2013) Non-oxidative ethanol metabolites as a measure of alcohol intake. Clin Chim Acta 415:322-329.
18. Maisto SA, Sobell LC, Cooper AM, Sobell MB (1982) Comparison of two techniques to obtain retrospective reports of drinking behavior from alcohol abusers. Addict Behav 7:33-38.
19. Marques P, Hansson T, Isaksson A, Walther L, Jones J, Lewis D, Jones M (2011) Detection of phosphatidylethanol (PEth) in the blood of drivers in an alcohol ignition interlock program. Traffic Inj Prev 12:136-141.
20. Marques PR, McKnight AS (2009) Field and laboratory alcohol detection with 2 types of transdermal devices. Alcohol Clin Exp Res 33:703-711.
21. Marques P, Tippetts S, Allen J, Javors M, Alling C, Yegles M, Pragst F, Wurst F (2010) Estimating driver risk using alcohol biomarkers, interlock blood alcohol concentration tests and psychometric assessments: initial descriptives. Addiction 105:226-239.
22. Miller PM, Anton RF, Egan BM, Basile J, Nguyen SA (2005) Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens (Greenwich) 7:346-351.
23. Nalesso A, Viel G, Cecchetto G, Mioni D, Pessa G, Favretto D, Ferrara SD (2011) Quantitative profiling of phosphatidylethanol molecular species in human blood by liquid chromatography high resolution mass spectrometry. J Chromatogr A 1218:8423-8431.
24. Roache JD, Karns TE, Hill-Kapturczak N, Mullen J, Liang Y, Lamb RJ, Dougherty DM (2015) Using transdermal alcohol monitoring to detect low-level drinking. Alcohol Clin Exp Res 39:1120-1127.
25. Sakai JT, Mikulich-Gilbertson SK, Long RJ, Crowley TJ (2006) Validity of transdermal alcohol monitoring: fixed and self-regulated dosing. Alcohol Clin Exp Res 30:26-33.
26. Stewart SH, Law TL, Randall PK, Newman R (2010) Phosphatidylethanol and alcohol consumption in reproductive age women. Alcohol Clin Exp Res 34:488-492.
27. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84:1353-1357.
28. Viel G, Boscolo-Berto R, Cecchetto G, Fais P, Nalesso A, Ferrara SD (2012) Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis. Int J Mol Sci 13:14788-14812.
29. Zheng Y, Beck O, Helander A (2011) Method development for routine liquid chromatography-mass spectrometry measurement of the alcohol biomarker phosphatidylethanol (PEth) in blood. Clin Chim Acta 412:1428-1435.